Evaluation of New Drugs - Risk Assessment

• Preclinical profile

• QT effects in humans

  • Mean & mean max changes c/w PBO
  • Categorical analysis
  • Outliers
  • Special populations

• Torsades de Pointes

• VT, VF & cardaic arrest

• Syncope

• Sudden death

Previous slide

Next slide

Back to first slide

View graphic version